Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug-drug interactions through the FDA adverse event reporting system.

Antonazzo IC, Poluzzi E, Forcesi E, Salvo F, Pariente A, Marchesini G, De Ponti F, Raschi E.

Acta Diabetol. 2019 Jun 15. doi: 10.1007/s00592-019-01378-7. [Epub ahead of print]

PMID:
31203438
2.

Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list?

Raschi E, Antonazzo IC, Poluzzi E, De Ponti F.

Ann Rheum Dis. 2019 Jun 12. pii: annrheumdis-2019-215819. doi: 10.1136/annrheumdis-2019-215819. [Epub ahead of print] No abstract available.

PMID:
31189551
3.

Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System.

Raschi E, Mazzarella A, Antonazzo IC, Bendinelli N, Forcesi E, Tuccori M, Moretti U, Poluzzi E, De Ponti F.

Target Oncol. 2019 Apr;14(2):205-221. doi: 10.1007/s11523-019-00632-w.

PMID:
30927173
4.

Dapagliflozin and cardiovascular outcomes: anything else to DECLARE?

Raschi E, Poluzzi E, Marchesini G, De Ponti F.

Expert Opin Pharmacother. 2019 Jun;20(9):1087-1090. doi: 10.1080/14656566.2019.1598970. Epub 2019 Mar 28.

PMID:
30920851
5.

Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres.

Berardi L, Antonazzo IC, Piccinni C, Raschi E, Forcesi E, Fioritti A, Berardi D, De Ponti F, Piazza A, Poluzzi E.

PLoS One. 2019 Feb 15;14(2):e0211938. doi: 10.1371/journal.pone.0211938. eCollection 2019.

6.

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas.

Roberto G, Barone-Adesi F, Giorgianni F, Pizzimenti V, Ferrajolo C, Tari M, Bartolini C, Da Cas R, Maggini M, Spila-Alegiani S, Francesconi P, Trifirò G, Poluzzi E, Baccetti F, Gini R.

BMC Endocr Disord. 2019 Feb 7;19(1):18. doi: 10.1186/s12902-019-0334-y.

7.

Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease.

Raschi E, Mazzotti A, Poluzzi E, De Ponti F, Marchesini G.

Expert Opin Pharmacother. 2018 Dec;19(17):1903-1914. doi: 10.1080/14656566.2018.1531126. Epub 2018 Oct 9. Review.

PMID:
30299993
8.

The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?

Trifirò G, Gini R, Barone-Adesi F, Beghi E, Cantarutti A, Capuano A, Carnovale C, Clavenna A, Dellagiovanna M, Ferrajolo C, Franchi M, Ingrasciotta Y, Kirchmayer U, Lapi F, Leone R, Leoni O, Lucenteforte E, Moretti U, Mugelli A, Naldi L, Poluzzi E, Rafaniello C, Rea F, Sultana J, Tettamanti M, Traversa G, Vannacci A, Mantovani L, Corrao G.

Drug Saf. 2019 Mar;42(3):347-363. doi: 10.1007/s40264-018-0732-5. Review.

PMID:
30269245
9.

Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System.

Mei R, Raschi E, Forcesi E, Diemberger I, De Ponti F, Poluzzi E.

Int J Cardiol. 2018 Dec 15;273:183-186. doi: 10.1016/j.ijcard.2018.09.054. Epub 2018 Sep 14. No abstract available.

PMID:
30236504
10.

Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System.

Antonazzo IC, Poluzzi E, Forcesi E, Riise T, Bjornevik K, Baldin E, Muratori L, De Ponti F, Raschi E.

Mult Scler. 2018 Sep 19:1352458518799598. doi: 10.1177/1352458518799598. [Epub ahead of print]

PMID:
30230957
11.

Reporting of immune checkpoint inhibitor-associated myocarditis.

Raschi E, Diemberger I, Poluzzi E, De Ponti F.

Lancet. 2018 Aug 4;392(10145):383. doi: 10.1016/S0140-6736(18)31549-6. No abstract available.

PMID:
30102168
12.

Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System.

Antonazzo IC, Raschi E, Forcesi E, Riise T, Bjornevik K, Baldin E, De Ponti F, Poluzzi E.

Expert Opin Drug Saf. 2018 Sep;17(9):869-874. doi: 10.1080/14740338.2018.1506763. Epub 2018 Aug 11.

PMID:
30058390
13.

Drug-induced Kounis syndrome: A matter of pharmacovigilance.

Raschi E, Fertonani Affini L, Antonazzo IC, Diemberger I, Poluzzi E, De Ponti F.

Int J Cardiol. 2019 Jan 1;274:381. doi: 10.1016/j.ijcard.2018.07.119. Epub 2018 Jul 24. No abstract available.

PMID:
30057169
14.

Observational research on sodium glucose co-transporter-2 inhibitors: A real breakthrough?

Raschi E, Poluzzi E, Fadini GP, Marchesini G, De Ponti F.

Diabetes Obes Metab. 2018 Dec;20(12):2711-2723. doi: 10.1111/dom.13468. Epub 2018 Aug 14. Review.

15.

Recurrence of pericarditis after influenza vaccination: a case report and review of the literature.

Mei R, Raschi E, Poluzzi E, Diemberger I, De Ponti F.

BMC Pharmacol Toxicol. 2018 May 5;19(1):20. doi: 10.1186/s40360-018-0211-8. Review.

16.

Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis.

Mouchet J, Salvo F, Raschi E, Poluzzi E, Antonazzo IC, De Ponti F, Bégaud B.

Pharmacol Res. 2018 Jun;132:108-118. doi: 10.1016/j.phrs.2018.04.007. Epub 2018 Apr 14.

PMID:
29665426
17.

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems.

Raschi E, Poluzzi E, Salvo F, Pariente A, De Ponti F, Marchesini G, Moretti U.

Nutr Metab Cardiovasc Dis. 2018 Jun;28(6):533-542. doi: 10.1016/j.numecd.2018.02.014. Epub 2018 Mar 1. Review.

PMID:
29625780
18.

Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems.

Raschi E, Girardi A, Poluzzi E, Forcesi E, Menniti-Ippolito F, Mazzanti G, De Ponti F.

Drug Saf. 2018 Aug;41(8):745-752. doi: 10.1007/s40264-018-0661-3.

PMID:
29582393
19.

Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health.

Mostacci B, Bisulli F, Poluzzi E, Cocchi G, Piccinni C, Curti A, Simonazzi G, Astolfi G, Rizzo N, Zenesini C, D'Alessandro R, Tinuper P; and the ESPEA Study Group.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):983-988. doi: 10.1136/jnnp-2017-317833. Epub 2018 Mar 16.

20.

Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis.

Mouchet J, Salvo F, Raschi E, Poluzzi E, Antonazzo IC, De Ponti F, Bégaud B.

Vaccine. 2018 Mar 14;36(12):1548-1555. doi: 10.1016/j.vaccine.2018.02.036. Epub 2018 Feb 15. Review.

PMID:
29454521
21.

No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase.

Carnovale C, Raschi E, Leonardi L, Moretti U, De Ponti F, Gentili M, Pozzi M, Clementi E, Poluzzi E, Radice S.

Expert Rev Vaccines. 2018 Apr;17(4):363-381. doi: 10.1080/14760584.2018.1442718. Epub 2018 Mar 9.

22.

Diabetes is associated with decreased migraine risk: A nationwide cohort study.

Antonazzo IC, Riise T, Cortese M, Berge LI, Engeland A, Bernt Fasmer O, Lund A, Joachim Ødegaard K, Poluzzi E, Bjornevik K.

Cephalalgia. 2018 Oct;38(11):1759-1764. doi: 10.1177/0333102417748573. Epub 2017 Dec 17.

PMID:
29249165
23.

Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems.

Raschi E, Parisotto M, Forcesi E, La Placa M, Marchesini G, De Ponti F, Poluzzi E.

Nutr Metab Cardiovasc Dis. 2017 Dec;27(12):1098-1107. doi: 10.1016/j.numecd.2017.10.008. Epub 2017 Oct 18.

PMID:
29174026
24.

Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project.

Poluzzi E, Diemberger I, De Ridder M, Koci A, Clo M, Oteri A, Pecchioli S, Bezemer I, Schink T, Pilgaard Ulrichsen S, Boriani G, Sturkenboom MCJ, De Ponti F, Trifirò G.

Eur J Clin Pharmacol. 2017 Nov;73(11):1499-1510. doi: 10.1007/s00228-017-2317-0. Epub 2017 Aug 22.

PMID:
28831527
25.

Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based study.

Mostacci B, Poluzzi E, D'Alessandro R, Cocchi G, Tinuper P; ESPEA Study Group.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):223-224. doi: 10.1136/jnnp-2017-316143. Epub 2017 Jul 17. No abstract available. Erratum in: J Neurol Neurosurg Psychiatry. 2018 May;89(5):e1.

PMID:
28716783
26.

Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.

Antonazzo IC, Raschi E, Vignatelli L, Baldin E, Riise T, D'Alessandro R, De Ponti F, Poluzzi E.

Drug Saf. 2017 Sep;40(9):823-834. doi: 10.1007/s40264-017-0551-0. Review.

PMID:
28597251
27.

Use of azithromycin and risk of ventricular arrhythmia.

Trifirò G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S, Mazzaglia G, Bezemer I, Garbe E, Schink T, Poluzzi E, Frøslev T, Molokhia M, Diemberger I, Sturkenboom MCJM.

CMAJ. 2017 Apr 18;189(15):E560-E568. doi: 10.1503/cmaj.160355.

28.

Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit.

Girardi A, Galletti S, Raschi E, Koci A, Poluzzi E, Faldella G, De Ponti F.

Ital J Pediatr. 2017 Apr 17;43(1):37. doi: 10.1186/s13052-017-0354-z.

29.

Drug-Induced Arrhythmia: Bridging the Gap Between Pathophysiological Knowledge and Clinical Practice.

Poluzzi E, Raschi E, Diemberger I, De Ponti F.

Drug Saf. 2017 Jun;40(6):461-464. doi: 10.1007/s40264-017-0529-y. No abstract available.

PMID:
28389980
30.

Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development.

Girardi A, Raschi E, Galletti S, Allegaert K, Poluzzi E, De Ponti F.

Expert Opin Drug Metab Toxicol. 2017 May;13(5):555-565. doi: 10.1080/17425255.2017.1290081. Epub 2017 Feb 13. Review.

PMID:
28141945
31.

Association between the use of proton pump inhibitors and cardiovascular events: A note of caution.

Raschi E, Bianchin M, Poluzzi E, De Ponti F.

Neurogastroenterol Motil. 2017 Feb;29(2). doi: 10.1111/nmo.12977. No abstract available.

PMID:
28132439
32.

Stroke, Migraine and Triptans: From Bedside to Bench.

Raschi E, Poluzzi E, De Ponti F.

EBioMedicine. 2016 Apr;6:14-15. doi: 10.1016/j.ebiom.2016.03.045. Epub 2016 Apr 6. No abstract available.

33.

Safety Meta-Analysis: A Call for Appropriate Use of Disproportionality Measures From Spontaneous Reporting Systems.

Raschi E, Salvo F, Poluzzi E, De Ponti F.

J Am Coll Cardiol. 2016 May 10;67(18):2193. doi: 10.1016/j.jacc.2016.01.082. No abstract available.

34.

Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System.

Raschi E, Poluzzi E, Koci A, Antonazzo IC, Marchesini G, De Ponti F.

Nutr Metab Cardiovasc Dis. 2016 May;26(5):380-6. doi: 10.1016/j.numecd.2016.02.006. Epub 2016 Feb 19.

PMID:
27067162
35.

Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs.

Oteri A, Mazzaglia G, Pecchioli S, Molokhia M, Ulrichsen SP, Pedersen L, Poluzzi E, De Ponti F, Garbe E, Schink T, Herings R, Bezemer ID, Sturkenboom MC, Trifirò G.

Br J Clin Pharmacol. 2016 Aug;82(2):487-97. doi: 10.1111/bcp.12955. Epub 2016 May 18. Erratum in: Br J Clin Pharmacol. 2017 Jun;83(6):1360.

36.

Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy.

Lodato F, Poluzzi E, Raschi E, Piccinni C, Koci A, Olivelli V, Napoli C, Corvalli G, Nalon E, De Ponti F, Zoli M.

Eur J Intern Med. 2016 May;30:31-36. doi: 10.1016/j.ejim.2016.01.025. Epub 2016 Feb 28.

PMID:
26926561
37.

Authors' Reply to Alain Braillon's Comment on "The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project".

Raschi E, Poluzzi E, Salvo F, Moretti U, De Ponti F.

Drug Saf. 2016 Apr;39(4):367-8. doi: 10.1007/s40264-016-0404-2. No abstract available.

PMID:
26895342
38.

Prescription patterns of antiepileptic drugs in young women: development of a tool to distinguish between epilepsy and psychiatric disorders.

Naldi I, Piccinni C, Mostacci B, Renzini J, Accetta G, Bisulli F, Tappatà M, Piazza A, Pagano P, Bianchi S, D'Alessandro R, Tinuper P, Poluzzi E; ESPEA (Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs) Group.

Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):763-9. doi: 10.1002/pds.3984. Epub 2016 Feb 17.

PMID:
26887800
39.

[The key role of patient in the antipsychotic therapy: shared decision making, adherence and research].

Gallingani F, Piccinni C, Simeoni A, Poluzzi E, Menchetti M, Berardi D.

Recenti Prog Med. 2015 Nov;106(11):551-63. doi: 10.1701/2074.22492. Review. Italian.

PMID:
26668041
40.

The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.

Raschi E, Poluzzi E, Salvo F, Koci A, Suling M, Antoniazzi S, Perina L, Hazell L, Moretti U, Sturkenboom M, Garbe E, Pariente A, De Ponti F.

Drug Saf. 2016 Jan;39(1):59-68. doi: 10.1007/s40264-015-0353-1.

41.

Response to comment on: "antibiotic use varies substantially among adults--a cross‑national study from five European Countries in the ARITMO project".

Mor A, Thomsen RW, Frøslev T, Garbe E, Poluzzi E, Sturkenboom MC, Trifirò G, Søgaard M.

Infection. 2016 Feb;44(1):135-41. doi: 10.1007/s15010-015-0829-z. Epub 2015 Sep 16. No abstract available.

PMID:
26377832
42.

Erratum to: Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project.

Mor A, Frøslev T, Thomsen RW, Oteri A, Rijnbeek P, Schink T, Garbe E, Pecchioli S, Innocenti F, Bezemer I, Poluzzi E, Sturkenboom MC, Trifirò G, Søgaard M.

Infection. 2016 Feb;44(1):145-50. doi: 10.1007/s15010-015-0835-1. No abstract available.

PMID:
26358972
43.

Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice.

Raschi E, Piccinni C, Signoretta V, Lionello L, Bonezzi S, Delfino M, Di Candia L, Di Castri L, Pieraccini F, Carati D, Poluzzi E, De Ponti F; Emilia-Romagna elderly poly-treated patients research group.

Br J Clin Pharmacol. 2015 Dec;80(6):1411-20. doi: 10.1111/bcp.12754. Epub 2015 Nov 12.

44.

Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy.

Poluzzi E, Veronese G, Piccinni C, Raschi E, Koci A, Pagano P, Godman B, Marchesini G, Boriani G, De Ponti F.

Basic Clin Pharmacol Toxicol. 2016 Jan;118(1):63-9. doi: 10.1111/bcpt.12442. Epub 2015 Aug 2.

45.

Trends in paediatric macrolide use in five European countries-a population-based study.

Holstiege J, Enders D, Schink T, Innocenti F, Oteri A, Bezemer I, Kaguelidou F, Molokhia M, Poluzzi E, Puccini A, Ulrichsen SP, Sturkenboom MC, Trifirò G, Garbe E.

Eur J Clin Pharmacol. 2015 Aug;71(8):991-9. doi: 10.1007/s00228-015-1870-7. Epub 2015 May 22.

PMID:
25998220
46.

Drug-induced renal damage in preterm neonates: state of the art and methods for early detection.

Girardi A, Raschi E, Galletti S, Poluzzi E, Faldella G, Allegaert K, De Ponti F.

Drug Saf. 2015 Jun;38(6):535-51. doi: 10.1007/s40264-015-0288-6. Review.

47.

Social and clinical descriptors of antipsychotic prescription.

Piccinni C, Piazza A, Poluzzi E, Tarricone I, Koci A, Berardi D, Fioritti A, de Ponti F.

Int J Psychiatry Med. 2015;49(1):45-62. doi: 10.2190/PM.49.1.d.

PMID:
25838320
48.

Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project.

Mor A, Frøslev T, Thomsen RW, Oteri A, Rijnbeek P, Schink T, Garbe E, Pecchioli S, Innocenti F, Bezemer I, Poluzzi E, Sturkenboom MC, Trifirò G, Søgaard M.

Infection. 2015 Aug;43(4):453-72. doi: 10.1007/s15010-015-0768-8. Epub 2015 Apr 1. Erratum in: Infection. 2016 Feb;44(1):145-50.

PMID:
25828936
49.

Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe.

Poluzzi E, Raschi E, Godman B, Koci A, Moretti U, Kalaba M, Wettermark B, Sturkenboom M, De Ponti F.

PLoS One. 2015 Mar 18;10(3):e0119551. doi: 10.1371/journal.pone.0119551. eCollection 2015.

50.

Comment on: "Pharmacokinetics in patients with chronic liver disease and hepatic safety of incretin-based therapies for the management of type 2 diabetes mellitus".

Raschi E, Poluzzi E, De Ponti F.

Clin Pharmacokinet. 2015 Apr;54(4):447-8. doi: 10.1007/s40262-015-0248-4. No abstract available.

PMID:
25721222

Supplemental Content

Loading ...
Support Center